What is the impact of PRIME on real-life diabetic nephropathy?RUILOPE, L. M.International journal of clinical practice (Esher). 2004, Vol 58, Num 3, pp 268-276, issn 1368-5031, 9 p.Article

Glutamine:fructose-6-phosphate aminotransferase enzyme activity is necessary for the induction of TGF-β1 and fibronectin expression in mesangial cellsWEIGERT, C; FRIESS, U; BRODBECK, K et al.Diabetologia (Berlin). 2003, Vol 46, Num 6, pp 852-855, issn 0012-186X, 4 p.Article

Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathyDAVIS, B. J; JOHNSTON, C. I; BURRELL, L. M et al.Diabetologia (Berlin). 2003, Vol 46, Num 7, pp 961-971, issn 0012-186X, 11 p.Article

Tumor marker pyruvate kinase type tumor M2 in patients suffering from diabetic nephropathyOREMEK, G. M; RUTNER, F; SAPOUTZIS, N et al.Anticancer research. 2003, Vol 23, Num 2A, pp 1155-1158, issn 0250-7005, 4 p.Conference Paper

In situ protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathyIORI, E; MARESCOTTI, M. C; VEDOVATO, M et al.Diabetologia (Berlin). 2003, Vol 46, Num 4, pp 524-530, issn 0012-186X, 7 p.Article

Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat modelOTA, T; TAKAMURA, T; ANDO, H et al.Diabetologia (Berlin). 2003, Vol 46, Num 6, pp 843-851, issn 0012-186X, 9 p.Article

Chronic endothelin receptor blockade prevents both early hyperfiltration and late overt diabetic nephropathy in the ratDING, Shuang-Shuang; CHANGBIN QIU; HESS, Patrick et al.Journal of cardiovascular pharmacology. 2003, Vol 42, Num 1, pp 48-54, issn 0160-2446, 7 p.Article

E-selectin-inducing activity in plasma from type 2 diabetic patients with maculopathyKNUDSEN, S. T; FOSS, C. H; POULSEN, P. L et al.American journal of physiology. Endocrinology and metabolism. 2003, Vol 47, Num 1, pp 1-6, issn 0193-1849, 6 p.Article

ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathyGROSS, M.-L; EL-SHAKMAK, A; SZABO, A et al.Diabetologia (Berlin). 2003, Vol 46, Num 6, pp 856-868, issn 0012-186X, 13 p.Article

Polymorphisms of eNDS gene are associated with diabetic nephropathy: a meta-analysisYANMING HE; ZHAOHUA FAN; JIYUAN ZHANG et al.Mutagenesis. 2011, Vol 26, Num 2, pp 339-349, issn 0267-8357, 11 p.Article

Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetesLOOKER, H. C; FAGOT-CAMPAGNA, A; GUNTER, E. W et al.Diabetologia (Berlin). 2003, Vol 46, Num 6, pp 766-772, issn 0012-186X, 7 p.Article

Familial factors in diabetic nephropathy : an offspring studyAGIUS, E; ATTARD, G; SHAKESPEARE, L et al.Diabetic medicine. 2006, Vol 23, Num 3, pp 331-334, issn 0742-3071, 4 p.Article

MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1FENG HE; FENFEN PENG; XI XIA et al.Diabetologia (Berlin). 2014, Vol 57, Num 8, pp 1726-1736, issn 0012-186X, 11 p.Article

Novel genetic susceptibility loci for diabetic end-stage renal disease identified through robust naive Bayes classificationSAMBO, Francesco; MALOVINI, Alberto; SARAHEIMO, Markku et al.Diabetologia (Berlin). 2014, Vol 57, Num 8, pp 1611-1622, issn 0012-186X, 12 p.Article

A method for isolation and identification of urinary biomarkers in patients with diabetic nephropathyFISHER, Wayne G; LUCAS, Jessica E; MEHDI, Uzma F et al.Proteomics. Clinical applications (Print). 2011, Vol 5, Num 11-12, pp 603-612, issn 1862-8346, 10 p.Article

Finding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysisHANSEN, Henning G; OVERGAARD, Julie; LAJER, Maria et al.Proteomics. Clinical applications (Print). 2010, Vol 4, Num 8-9, pp 697-705, issn 1862-8346, 9 p.Article

Identification of diabetic nephropathy-selective proteins in human plasma by multi-lectin affinity chromatography and LC-MS/MSAHN, Jung-Mo; KIM, Byung-Gyu; YU, Myong-Hee et al.Proteomics. Clinical applications (Print). 2010, Vol 4, Num 6-7, pp 644-653, issn 1862-8346, 10 p.Article

Alterations of the podocyte proteome in response to high glucose concentrationsSCHORDAN, Sandra; SCHORDAN, Eric; ENDLICH, Nicole et al.Proteomics (Weinheim. Print). 2009, Vol 9, Num 19, pp 4519-4528, issn 1615-9853, 10 p.Article

Anaemia in diabetes : is there a rationale to TREAT?THOMAS, M. C; COOPER, M. E; ROSSING, K et al.Diabetologia (Berlin). 2006, Vol 49, Num 6, pp 1151-1157, issn 0012-186X, 7 p.Article

Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linköping Diabetes Complications StudyNORDWALL, M; BOJESTIG, M; ARNQVIST, H. J et al.Diabetologia (Berlin). 2004, Vol 47, Num 7, pp 1266-1272, issn 0012-186X, 7 p.Article

Therapeutic effect of recombinant human erythropoietin on anaemia with erythropoietin deficiency in diabetic patientsKIM, D. J; KIM, Y. M; LEE, H. C et al.Diabetic medicine. 2003, Vol 20, Num 8, pp 661-664, issn 0742-3071, 4 p.Article

Survival in dialysis patients is different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid conditionSCHROIJEN, M. A; VAN DE LUIJTGAARDEN, M. W. M; WANNER, C et al.Diabetologia (Berlin). 2013, Vol 56, Num 9, pp 1949-1957, issn 0012-186X, 9 p.Article

Different expression of Fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathyGIANAZZA, E; MAININI, V; MAGNI, F et al.Journal of proteomics (Print). 2010, Vol 73, Num 3, pp 593-601, issn 1874-3919, 9 p.Article

Long-term effect of modification of dietary protein intake on the progression of diabetic nephropathy: a randomised controlled trialKOYA, D; HANEDA, M; ARAKI, S. I et al.Diabetologia (Berlin). 2009, Vol 52, Num 10, pp 2037-2045, issn 0012-186X, 9 p.Article

Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathyWIJNHOVEN, T. J. M; VAN DEN HOVEN, M. J. W; DING, H et al.Diabetologia (Berlin). 2008, Vol 51, Num 2, pp 372-382, issn 0012-186X, 11 p.Article